Valuation
$177.6M
2024 Revenue
$59.2M
Customers
5K
Funding
$87.2M
Avg ACV
$11.8K
Team
251
Founded
2016
How Popmenu CEO Brendan Sweeney grew to $59.2M revenue and 5K customers in 2024.
Popmenu is a SaaS company that helps restaurants turn their menu into a customer conversion engine.
Last updated
Popmenu Revenue
In 2024, Popmenu's revenue reached $59.2M. Since its launch in 2016, Popmenu has shown consistent revenue growth.
| Year | Milestone | Quote |
|---|---|---|
| 2024 | Popmenu Hit $59.2m revenue in June 2024 | |
| 2016 | Launched with $0 revenue |
Popmenu Valuation, Funding Rounds
Popmenu's most recent disclosed valuation is $177.6M.
Popmenu has raised $87.2M in total funding across 4 rounds, most recently a $65M Series C round in 2021.
| Year | Round | Amount | Valuation | % Sold | Quote |
|---|---|---|---|---|---|
| 2021 | Series C | $65M | - | - | |
| 2020 | Series B | $17M | - | - | |
| 2019 | Series A | $4.6M | - | - | |
| 2018 | Seed Round | $585K | - | - |
Founder / CEO
Q&A
| Question | Answer |
|---|---|
| What's your age? | - |
| Favorite online tool? | - |
| Favorite book? | - |
| Favorite CEO? | - |
| Advice for 20 year old self | - |
Customers
Popmenu serves 5K customers.
Popmenu Employees & Team Size
Popmenu employs approximately 251 people as of 2026, including 58 sales reps that carry a quota. It serves 5K customers that rely on its solutions.
| Year | Milestone |
|---|---|
| 2024 | Reached 251 employees (October 2024) |
| 2021 | Reached 251 employees (October 2021) |
Frequently Asked Questions about Popmenu
What is Popmenu's revenue?
Popmenu generates an estimated $59.2M in annual revenue.
Who founded Popmenu?
Popmenu was founded by Brendan Sweeney.
Who is the CEO of Popmenu?
The CEO of Popmenu is Brendan Sweeney.
How much funding does Popmenu have?
Popmenu raised $87.2M across 4 rounds.
How many employees does Popmenu have?
Popmenu has 251 employees.
Where is Popmenu headquarters?
Popmenu is headquartered in United States.
Compare Popmenu to the industry
Popmenu operates across multiple industries. Browse revenue, funding, and growth data for Popmenu in each sector below.
Data and Sources
All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.
Claim this profilePeople Also Viewed
Boom
Economically and environmentally sustainable supersonic travel
porter.in
Porter is a leading logistics service provider offering a wide range of goods transportation solutions. They operate as a provider of on-demand transportation solutions for goods and intercity courier services, aiming to streamline and optimize last-mile delivery operations.
U.S. Compliance
U.S. Compliance specializes in Regulatory Compliance Management and Consulting, providing OSHA compliance and environmental compliance solutions. The company has nearly 30 years of experience in environmental, health, and safety consulting.
Fay Nutrition
Fay helps users choose a dietitian, arranges virtual and in-person meetings, designs a custom plan for each client, and works with insurance to get it covered, enabling people to receive fully customized nutrition counseling at an affordable price.
ABL
With a 60+ year history as a service provider to the life sciences industry, Advanced BioScience Laboratories (ABL) provides a strong core of product development expertise, GMP manufacturing, and analytical testing capabilities. Founded in 1961 as a biomedical research contractor for the federal government, ABL has made major contributions to the development and evaluation of a wide range of life-saving diagnostics, vaccines, and therapeutics designed to combat the world’s most challenging diseases. We partner with our clients to support advancement of their candidate vaccines and therapeutics through preclinical and clinical development. With facilities located in the United States, ABL aims to be a seamless extension of our clients’ team – helping them advance today’s ideas into tomorrow’s medicines. ABL's CDMO service division specializes in the development and manufacturing of GMP cell banks and viral vectors from the bench to Phase I/II clinical trials. We aim to contributes to the success of our clients' ground-breaking innovations, including gene therapies, immunotherapies, viral vaccines, oncolytic viruses, and more. ABL's CDMO services include bulk drug substance production, fill/finish of drug products, process development, assay development and release testing.
Affle
Affle 3i Limited is a global technology company enabling AI-led solutions in mobile advertising. Affle enables advertisers to optimize targeting, personalize user engagement and maximize ROI by combining proprietary data, deep audience insights and advanced generative AI capabilities. With our market-leading portfolio of tech platforms, we empower brands to move beyond automation toward next-gen experiences with measurable impact. Our consumer intelligence platforms deliver personalized solutions at scale, helping marketers connect with audiences in more relevant and meaningful ways. With innovative tech-powered capabilities, we drive performance across every stage of the mobile marketing journey. We are augmenting our authentic intelligence with AI-powered agents and algorithms, going beyond efficiency to adapt in real time and influence outcomes that matter. Affle 3i Limited is listed on the NSE (AFFLE) and BSE (542752).
